Context:

Cirrhosis results from prolonged liver damage, leading to extensive scarring, often due to conditions like hepatitis or chronic alcohol consumption. The data provided is sourced from a Mayo Clinic study on primary biliary cirrhosis (PBC) of the liver carried out from 1974 to 1984.

I have manually cleaned the dataset and used synthetic data to increase samples.

Attribute Information:

• N_Days: Number of days between registration and the earlier of death, transplantation, or study analysis time in 1986
• Status: status of the patient C (censored), CL (censored due to liver tx), or D (death)
• Drug: type of drug D-penicillamine or placebo
• Age: age in days
• Sex: M (male) or F (female)
• Ascites: presence of ascites N (No) or Y (Yes)
• Hepatomegaly: presence of hepatomegaly N (No) or Y (Yes)
• Spiders: presence of spiders N (No) or Y (Yes)
• Edema: presence of edema N (no edema and no diuretic therapy for edema), S (edema present without diuretics, or edema resolved by diuretics), or Y (edema despite diuretic therapy)
• Bilirubin: serum bilirubin in [mg/dl]
• Cholesterol: serum cholesterol in [mg/dl]
• Albumin: albumin in [gm/dl]
• Copper: urine copper in [ug/day]
• Alk_Phos: alkaline phosphatase in [U/liter]
• SGOT: SGOT in [U/ml]
• Tryglicerides: triglicerides in [mg/dl]
• Platelets: platelets per cubic [ml/1000]
• Prothrombin: prothrombin time in seconds [s]
• Stage: histologic stage of disease ( 1, 2, or 3 )

Citation:

Dickson,E., Grambsch,P., Fleming,T., Fisher,L., and Langworthy,A.. (2023). Cirrhosis Patient Survival Prediction. UCI Machine Learning Repository. https://doi.org/10.24432/C5R02G.